Novosanis is an innovative developer and producer of medical devices adding value to the accuracy of diagnostics tests as well as drug delivery in the field of prevention, detection and treatment of infectious diseases and oncology.
Novosanis is a Belgian company endorsed on multiple occasions nationally and internationally for its solutions and is ISO13485 certified.
Novosanis prospers in user-friendly and game-changing medical device solutions for self-sampling and drug delivery that improve accuracy and standardization while making handling easier, more consistent and more comfortable for the user.
Novosanis has two device platforms in portfolio:
VAX-ID™ is a patented and proven platform of injection devices suited for accurate drug delivery of e.g. vaccines in the dermal layer of the skin.
Colli-Pee™ is a patented sampling device suited for standardized and guaranteed collection of first-void urine (first 20ml of the urine flow) allowing improved detection of infectious diseases as well as early stage (urological) cancer. Colli-Pee™ is CE-marked and FDA listed.